Filter
673
Text search:
Stop
TB
Partnership,
World
Health
Organization
Featured
Recommendations
51
New Publications
186
Language
Document type
No document type
496
Studies & Reports
73
Guidelines
48
Strategic & Response Plan
23
Manuals
21
Fact sheets
6
Training Material
4
Brochures
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
26
Kenya
21
India
20
Global
19
Nepal
18
Eastern Europe
18
Rwanda
15
Bangladesh
14
Liberia
13
Uganda
13
Zambia
13
Ethiopia
12
Asia
12
Tanzania
11
South Africa
11
Myanmar / Burma
11
Cambodia
10
Malawi
9
Nigeria
8
Sierra Leone
7
Ukraine
7
Latin America and the Carribbean
7
Ghana
6
Philippines
6
Mozambique
6
Botswana
6
Indonesia
5
South–East Asia Region
5
Senegal
4
Zimbabwe
4
Namibia
4
Africa
4
Pakistan
3
Germany
3
Lesotho
3
Timor Leste/ East Timor
3
Russia
3
Guinea
2
Congo, Democratic Republic of
2
South Sudan
2
Thailand
2
Benin
2
Argentina
2
Eswatini/ Swaziland
2
Brazil
2
Colombia
2
Sri Lanka
2
Bhutan
2
Cameroon
1
Haiti
1
Somalia
1
Iraq
1
Afghanistan
1
Syria
1
Gambia
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Dominican Republic
1
Burundi
1
Honduras
1
El Salvador
1
Guatemala
1
Nicaragua
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Venezuela
1
North Korea
1
Albania
1
Armenia
1
Southern Africa
1
Laos
1
Tajikistan
1
Bulgaria
1
Vietnam
1
Maldives
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
243
Clinical Guidelines
43
Public Health
22
Women & Child Health
11
Pharmacy & Technologies
11
Key Resources
10
Capacity Building
2
Toolboxes
TB
270
HIV
90
COVID-19
16
Health Financing Toolbox
15
Polio
14
AMR
12
NTDs
9
Caregiver
8
Ebola & Marburg
7
Conflict
6
Refugee
6
Global Health Education
6
Pharmacy
6
Disability
5
Natural Hazards
5
Rapid Response
4
Planetary Health
3
NCDs
3
Malaria
3
Mental Health
2
Cholera
1
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is
...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- an
...
Advocacy report March 2011
303100 03/2011 E 1,000
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, pu
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB c
...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of
...
20 April 2022. The response to the COVID-19 pandemic continues to adversely affect essential TB services in many countries. A first report of case studies was published in 2021 comprising 23 examples of innovative interventions implemented by countr
...
Guidelines for national programmes and other stakeholders
世界卫生组织 结核菌/艾滋病病毒双 重感染防治政策指南
——适用于国家规划 和利益攸关方
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing
...
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
Regional Eastern European and Central Asian project (TB-REP) Copenhagen, Denmark, 26–28 April 2016
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus eff
...
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NC
...